Skip to main content

Relaxing Immersive Virtual Reality Interventions Acceptable, Feasible

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Oct. 17, 2023 -- Relaxing immersive virtual reality (VR) interventions are acceptable and feasible and can offer benefits to patients with cancer, according to a review published online Oct. 16 in BMJ Supportive & Palliative Care.

William R.G. McGhee, from Queen's University in Belfast, and colleagues conducted a systematic review of the literature to examine immersive VR in adult populations with chronic physical illness to examine the impact on psychological well-being. A total of 31 studies met the inclusion criteria.

The researchers found that among adults with cancer, dementia, cardiovascular disease, kidney disease, and multiple sclerosis, relaxing and engaging immersive VR interventions were shown to be acceptable and feasible. The evidence about effectiveness was more limited because many of the studies reviewed were feasibility or pilot studies. Immersive VR was suggested to have a positive effect on anticipatory anxiety symptoms and pain, based on evidence mainly from patients with cancer.

"Our findings suggest that VR interventions are acceptable treatments that have the potential to improve physical and psychological consequences of physical illness," the authors write. "There is good-quality research to suggest that these VR interventions are effective in reducing pain and distress, particularly among people with cancer."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Read this next

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...

Self-, Partner-Reported Cognitive Decline Linked to Tau

THURSDAY, May 30, 2024 -- Individuals who self-report and whose partners report cognitive decline have greater tau, which is driven by elevated beta-amyloid (Aβ), according...

Recommendations Issued for Palliative RT for Symptomatic Bone Mets

THURSDAY, May 30, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online May 22 in Practical Radiation Oncology...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.